APOLLO HOSPITALS ENTER. L vs Coral Laboratories Ltd

A side-by-side comparison of APOLLO HOSPITALS ENTER. L (APOLLOHOSP) and Coral Laboratories Ltd (CORALAB) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

APOLLO HOSPITALS ENTER. L vs Coral Laboratories Ltd are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation13
  • Profitability22
  • Growth11
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

CORALAB takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

64.06
P/E ratio
8.49
12.55
P/B ratio
1.09
0.23%
Dividend yield
0.31%
₹135.04
EPS
₹67.63

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

22.10%
Return on equity
7.88%
18.00%
Return on capital
17.00%
15.00%
EBITDA margin
23.00%
7.94%
Net margin
20.87%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

14.94%
Revenue CAGR (3Y)
3.27%
33.39%
Profit CAGR (3Y)
42.41%

Size & financial health

APOLLOHOSP takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.24L Cr
Market cap
₹209 Cr
₹25,228 Cr
Revenue
₹115 Cr
₹2,003 Cr
Net profit
₹24 Cr
0.32
Debt / equity
0.02
APOLLO HOSPITALS ENTER. L
  • + ["Company has delivered good profit growth of 76.2% CAGR over last 5 years", "Company has been maintaining a healthy dividend payout of 17.7%"]
  • ["Stock is trading at 13.4 times its book value", "Company might be capitalizing the interest cost"]
Coral Laboratories Ltd
  • + ["Company is almost debt free.", "Stock is trading at 1.10 times its book value"]
  • ["The company has delivered a poor sales growth of -2.31% over past five years.", "Company has a low return on equity of 10.1% over last 3 years.", "Earnings include an other income of Rs.10.3 Cr.", "Working capital days have increased from 217 days to 328 days"]
APOLLO HOSPITALS ENTER. L full analysis Coral Laboratories Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.